Opinion
Civil Action No. 04-1078(JAG).
July 4, 2007
Gregory J. Bevelock, DECOTIIS, FITZPATRICK, COLE WISLER LLP, Teaneck, New Jersey.
Andrew P. Zappia, NIXON PEABODY LLP, Rochester, New York, Attorneys for Plaintiff AMR Technology Inc.
ORDER
THIS MATTER having come before the Court by DeCotiis, Fitzpatrick, Cole Wisler LLP attorneys for Plaintiff AMR Technology, Inc. ("AMR"), upon Motion to Seal Confidential Documents pursuant to L. Civ. P. 5.3(c) [Docket Entry # 168]; and the Court having previously entered a Protective Order on September 8, 2003; and Gregory J. Bevelock, Esquire, counsel for AMR stating that the letter "contains information designated by Teva Pharmaceuticals USA Inc. (`Teva') as `Confidential'" and that, "[u]pon information and belief, it is AMR's understanding that Teva would claim it would suffer substantial and specific harm, including but not limited to, potential financial damage, damage to business relationships, and/or other irreparable harm should any of the proprietary, commercial, and/or confidential" be disclosed in contravention of the terms of the September 8, 2003, Protective Order; and no opposition having been filed; and the Court finding that the document in question does contain confidential information; and the Court further finding that Teva could suffer financial harm should the information in question not be scaled; and the Court further finding that no less restrictive alternative exists; and the Court having reviewed AMR's submission; and the Court having considered this matter pursuant to Fed.R.Civ.P. 78; and for good cause shown;
IT IS, on this 4 day of July 2007,
ORDERED that Plaintiff AMR's Motion to Seal the April 30, 2007, letter to the Honorable Madeline Cox Arleo [Docket Entry # 169] is Granted.